BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 23255890)

  • 1. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.
    Gu Y; Zou YM; Lei D; Huang Y; Li W; Mo Z; Hu Y
    Sci Rep; 2017 Oct; 7(1):14200. PubMed ID: 29079774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA methylation in renal cell carcinoma.
    Shenoy N; Vallumsetla N; Zou Y; Galeas JN; Shrivastava M; Hu C; Susztak K; Verma A
    J Hematol Oncol; 2015 Jul; 8():88. PubMed ID: 26198328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
    Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
    J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypomethylation is prevalent even in low-grade breast cancers.
    Jackson K; Yu MC; Arakawa K; Fiala E; Youn B; Fiegl H; Müller-Holzner E; Widschwendter M; Ehrlich M
    Cancer Biol Ther; 2004 Dec; 3(12):1225-31. PubMed ID: 15539937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypomethylation and hemimethylation in cancer.
    Ehrlich M; Lacey M
    Adv Exp Med Biol; 2013; 754():31-56. PubMed ID: 22956495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma.
    Yoo KH; Park YK; Chang SG
    Oncol Lett; 2013 Jan; 5(1):39-42. PubMed ID: 23255890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CC chemokine receptor 5 in clear cell renal cell carcinoma and its clinical significance.
    Yoo KH; Lee DG; Won KY; Lim SJ; Park YK; Chang SG
    Oncol Lett; 2015 May; 9(5):2085-2089. PubMed ID: 26137017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
    Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
    Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
    Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
    Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma.
    Yoo KH; Won KY; Lim SJ; Park YK; Chang SG
    Oncol Lett; 2014 Nov; 8(5):2135-2139. PubMed ID: 25295100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas.
    Dimberg J; Ström K; Löfgren S; Zar N; Lindh M; Matussek A
    Int J Colorectal Dis; 2012 Jun; 27(6):709-14. PubMed ID: 22108905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
    Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
    Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.
    Martin D; Galisteo R; Gutkind JS
    J Biol Chem; 2009 Mar; 284(10):6038-42. PubMed ID: 19112107
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.